China · Delayed Price · Currency is CNY Jafron Biomedical Statistics
Total Valuation
SHE:300529 has a market cap or net worth of CNY 12.05 billion. The enterprise value is 10.90 billion.
| Market Cap | 12.05B |
| Enterprise Value | 10.90B |
Important Dates
The last earnings date was Friday, August 7, 2026.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | Jun 1, 2026 |
Share Statistics
SHE:300529 has 774.36 million shares outstanding. The number of shares has increased by 0.95% in one year.
| Current Share Class | 774.36M |
| Shares Outstanding | 774.36M |
| Shares Change (YoY) | +0.95% |
| Shares Change (QoQ) | +2.09% |
| Owned by Insiders (%) | 50.93% |
| Owned by Institutions (%) | 8.52% |
| Float | 374.61M |
Valuation Ratios
The trailing PE ratio is 23.11 and the forward PE ratio is 19.09.
| PE Ratio | 23.11 |
| Forward PE | 19.09 |
| PS Ratio | 6.31 |
| PB Ratio | 3.48 |
| P/TBV Ratio | 3.59 |
| P/FCF Ratio | 28.40 |
| P/OCF Ratio | 20.28 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.70, with an EV/FCF ratio of 25.70.
| EV / Earnings | 20.77 |
| EV / Sales | 5.71 |
| EV / EBITDA | 13.70 |
| EV / EBIT | 16.10 |
| EV / FCF | 25.70 |
Financial Position
The company has a current ratio of 2.11, with a Debt / Equity ratio of 0.36.
| Current Ratio | 2.11 |
| Quick Ratio | 1.86 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 1.55 |
| Debt / FCF | 2.92 |
| Interest Coverage | 13.16 |
Financial Efficiency
Return on equity (ROE) is 15.98% and return on invested capital (ROIC) is 23.89%.
| Return on Equity (ROE) | 15.98% |
| Return on Assets (ROA) | 8.09% |
| Return on Invested Capital (ROIC) | 23.89% |
| Return on Capital Employed (ROCE) | 17.49% |
| Weighted Average Cost of Capital (WACC) | 5.83% |
| Revenue Per Employee | 868,125 |
| Profits Per Employee | 238,667 |
| Employee Count | 2,200 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 1.49 |
Taxes
In the past 12 months, SHE:300529 has paid 119.36 million in taxes.
| Income Tax | 119.36M |
| Effective Tax Rate | 18.50% |
Stock Price Statistics
The stock price has decreased by -34.40% in the last 52 weeks. The beta is 0.33, so SHE:300529's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | -34.40% |
| 50-Day Moving Average | 16.64 |
| 200-Day Moving Average | 18.64 |
| Relative Strength Index (RSI) | 36.27 |
| Average Volume (20 Days) | 10,621,716 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300529 had revenue of CNY 1.91 billion and earned 525.07 million in profits. Earnings per share was 0.67.
| Revenue | 1.91B |
| Gross Profit | 1.47B |
| Operating Income | 677.33M |
| Pretax Income | 645.36M |
| Net Income | 525.07M |
| EBITDA | 793.28M |
| EBIT | 677.33M |
| Earnings Per Share (EPS) | 0.67 |
Balance Sheet
The company has 2.38 billion in cash and 1.24 billion in debt, with a net cash position of 1.15 billion or 1.48 per share.
| Cash & Cash Equivalents | 2.38B |
| Total Debt | 1.24B |
| Net Cash | 1.15B |
| Net Cash Per Share | 1.48 |
| Equity (Book Value) | 3.46B |
| Book Value Per Share | 4.47 |
| Working Capital | 1.47B |
Cash Flow
In the last 12 months, operating cash flow was 594.15 million and capital expenditures -169.89 million, giving a free cash flow of 424.25 million.
| Operating Cash Flow | 594.15M |
| Capital Expenditures | -169.89M |
| Depreciation & Amortization | 115.94M |
| Net Borrowing | -184.65M |
| Free Cash Flow | 424.25M |
| FCF Per Share | 0.55 |
Margins
Gross margin is 76.78%, with operating and profit margins of 35.46% and 27.49%.
| Gross Margin | 76.78% |
| Operating Margin | 35.46% |
| Pretax Margin | 33.79% |
| Profit Margin | 27.49% |
| EBITDA Margin | 41.54% |
| EBIT Margin | 35.46% |
| FCF Margin | 22.21% |
Dividends & Yields
This stock pays an annual dividend of 0.52, which amounts to a dividend yield of 3.29%.
| Dividend Per Share | 0.52 |
| Dividend Yield | 3.29% |
| Dividend Growth (YoY) | -35.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 81.34% |
| Buyback Yield | -0.95% |
| Shareholder Yield | 2.34% |
| Earnings Yield | 4.36% |
| FCF Yield | 3.52% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for SHE:300529 is 24.12, which is 55.01% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 24.12 |
| Price Target Difference | 55.01% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 7.87% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on May 20, 2020. It was a forward split with a ratio of 1.9.
| Last Split Date | May 20, 2020 |
| Split Type | Forward |
| Split Ratio | 1.9 |
Scores
SHE:300529 has an Altman Z-Score of 7.34 and a Piotroski F-Score of 5.
| Altman Z-Score | 7.34 |
| Piotroski F-Score | 5 |